Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake. (Q40180898)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

title

Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

0 references

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Anja Seubert

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Frank Liang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Gustaf Lindgren

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

11

Richard A Koup

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

10

Nancy J Sullivan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

author name string

Kerrie J Sandgren

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Elizabeth A Thompson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Joseph R Francica

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Ennio De Gregorio

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Susan Barnett

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Derek T O'Hagan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Robert A Seder

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

language of work or name

English

0 references

publication date

1 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

Science Translational Medicine

22 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

issue

393

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

Vaccine adjuvants: putting innate immunity to work

22 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

The mechanism of action of MF59 - an innately attractive adjuvant formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Dissociation of skeletal muscle for flow cytometric characterization of immune cells in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Local innate immune responses in the vaccine adjuvant-injected muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Rational design of small molecules as vaccine adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Analysis of immunoglobulin transcripts and hypermutation following SHIV(AD8) infection and protein-plus-adjuvant immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Oil-in-Water Emulsion MF59 Increases Germinal Center B Cell Differentiation and Persistence in Response to Vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Molecular and cellular signatures of human vaccine adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Coadministration of polyinosinic:polycytidylic acid and immunostimulatory complexes modifies antigen processing in dendritic cell subsets and enhances HIV gag-specific T cell immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

CD4 T follicular helper cell dynamics during SIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with high-risk melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Neutrophils efficiently cross-prime naive T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Murine neutrophils present Class II restricted antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Neutrophils control the magnitude and spread of the immune response in a thromboxane A2-mediated process

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

The B cell helper side of neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Programming the magnitude and persistence of antibody responses with innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Toll-like receptor 3 ligand and retinoic acid enhance germinal center formation and increase the tetanus toxoid vaccine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Human Anti-CD40 Antibody and Poly IC:LC Adjuvant Combination Induces Potent T Cell Responses in the Lung of Nonhuman Primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

Dendritic cell recruitment in response to skin antigen tests in HIV-1-infected individuals correlates with the level of T-cell infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAL2094

10.1126/SCITRANSLMED.AAL2094

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28592561%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference